Efforts to beat back the coronavirus are critical — they're also making clinical trials harder
from Stat News
In March, a team of Chinese scientists studying whether the antiviral remdesivir was effective against COVID-19 ran into a problem. “Stringent public health measures used in Wuhan led to marked reductions in new patient presentations,” the researchers wrote. Without enough patients enrolled, the study ended early.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063